期刊文献+

小剂量地西他滨联合异基因造血干细胞分次输注治疗老年骨髓增生异常综合征转急性髓性白血病2例报告 被引量:9

Low-dose decitabine combined with fractional allogeneic hematopoietic stem cell transfusion for treatment of elderly patients with acute myeloid leukemia transformed from myelodysplastic syndrome: a report of 2 cases
下载PDF
导出
摘要 目的观察小剂量地西他滨联合异基因造血干细胞分次输注(微移植)治疗老年骨髓增生异常综合征转急性髓性白血病(MDS-AML)的疗效。方法对2例确诊为MDS-AML患者分别予小剂量地西他滨或地西他滨联合CAG方案(阿糖胞苷+阿克拉霉素)化疗加微移植治疗,供者为人类白细胞抗原半相合的患者子女,采集重组人粒细胞集落刺激因子动员后的供者外周血干细胞,于化疗结束后约36 h分次输注。观察患者疾病状态、血小板水平、生存时间及不良反应情况。结果病例1、病例2治疗后复查骨髓均未缓解,生存时间分别为2个月和4个月。病例1治疗后血小板明显上升,最高达59×109/L,未输注血小板;病例2治疗后血小板输注间隔时间延长,并逐步脱离血小板输注。2例患者均未出现移植物抗宿主病。结论对于老年MDS-AML患者,小剂量地西他滨联合微移植虽不能达到治愈目的,但可延长生存期、提高血小板、改善患者的生活质量。 Objective To explore the efficay of low-dose decitabine combined with fractional allogeneic hematopoietic stem cell transfusion( micro transplantation) for treatment of elderly patients with acute myeloid leukemia transformed from myelodysplastic syndrome ( MDS-AML) .Methods Two patients diagnosed as MDS-AML were treated with chemotherapy regimen of low-dose decitabine or decitabine combined with CAG(cytosine arabinoside+aclacinomycin) and micro transplantation.The donors were children of patients with human leukocyte antigen semi-matched.Peripheral blood stem cells from the donors were mobilized with granulocyte colony-stimulating factor and then collected. Patients transfused PBSC about 36 hours after the chemotherapy finished.The disease status,platelet levels,survival timeand side effects were observed.Re sults Two cases did not achieve complete response.The survival times of Case 1 and Case 2 were 2 months and 4 months respectively. The platelet level in Case 1 increased remarkably after treatment,and reached to the maximal level of 59 ×10^9/L.No platelet transfusion was observed in Case 1.In Case 2,the interval of platelet transfusion was prolonged,and the patient was gradually independent on platelet transfusions. No graft-versus-host disease occurred in the two patients.Conclusion For elderly patients with MDS-AML,low-dose decitabine combined with micro transplantation can not cure the disease,but can prolong the survival time,increase the level of platelet and improve the quality of life.
出处 《广西医学》 CAS 2015年第10期1393-1396,共4页 Guangxi Medical Journal
基金 广西科技攻关计划项目(桂科攻1355005-2-1) 广西医药卫生科研课题(Z2014357)
关键词 骨髓增生异常综合征 急性髓性白血病 异基因造血干细胞 分次输注 地西他滨 血小板 老年人 Myelodysplastic syndrome Acute myeloid leukemia Allogeneic hematopoietic stem cell Fractional transfusion Decitabine Platlet Elderly
  • 相关文献

参考文献16

  • 1Juliusson G,Antunovic P,Derolf A,et al.Age and acute my- eloid leukemia:real world data on decision to treat and out- comes from the Swedish Acute Leukemia Registry[J].Blood,2009,113(18):4179-4187.
  • 2Lazarevic V,Horstedt AS,Johansson B,et al.Incidence and prognostic significance of karyotypic subgroups in older pa- tients with acute myeloid leukemia:the Swedish population- based experience[J].Blood Cancer J,2014,4(2):e188.
  • 3Ostgird LS,Kjeldsen E,Holm MS,et al.Reasons for treating secondary AML as de novo AML[J].Eur J Haematol,2010,85(3):217-226.
  • 4Appelbaum FR,Gundacker H,Head DR,et al.Age and acute myeloid leukemia[J].Blood,2006,107(9):3481-3485.
  • 5Bumett AK,Milligan D,Prentice AG,et al.A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelo- dysplastic syndrome in patients not considered fit for inten- sive treatment[J].Cancer,2007,109(6):1114-1124.
  • 6Jhanwar SC.Genetic and epigenetic pathways in myelodys- plastic syndromes:A brief overview[J].Adv Biol Regul,2014,58:28-37.
  • 7Mayer J,Arthur C,Delaunay J,et al.Multivariate and sub- group analyses of a randomized,multinational,phase 3 trial of decitabine vs treatment choice of supportive care or cytara- bine in older patients with newly diagnosed acute myeloid leukemia and poor-or intermediate-risk cytogenetics[J].BMC Cancer,2014,14:69.
  • 8Guo M,Hu KX,Yu CL,et al.Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemo- therapy for acute myeloid leukemia in elderly patients[J].Blood,2011,117(3):936-941.
  • 9Kong X,Chen Y,Wang L,et al.Effect of the microtransplant- ation of allogeneic hematopoietic stem cells as maintenance therapy for elderly patients with acute leukemia[J].Oncol Lett,2015,9(5):2331-2334.
  • 10Okuyama N,Sperr WR,Kadar K,et al.Prognosis of acute my- eloid leukemia transformed from myelodysplastic syndromes:a multicenter retrospective study[J].Leuk Res,2013,37(8):862-867.

同被引文献71

引证文献9

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部